Please login to the form below

Not currently logged in

Pollinex Quattro

This page shows the latest Pollinex Quattro news and features for those working in and with pharma, biotech and healthcare.

Allergy Tx hit hard as birch pollen product stumbles

Allergy Tx hit hard as birch pollen product stumbles

The trial started in 2017 and was designed to test the efficacy of the Pollinex Quattro Birch on the symptoms of allergic rhino-conjunctivitis due to birch pollen, as well as ... Two phase 2 studies revealed a significant 32% reduction in allergic

Latest news

  • Positive mid-stage trial gives Allergy’s investors some welcome relief Positive mid-stage trial gives Allergy’s investors some welcome relief

    All of the doses were safe and well-tolerated in the 447-patient study, according to Allergy, which was hit hard 11 years ago when the FDA placed its Pollinex Quattro

  • Leaning forward

    The company's flagship product is Pollinex Quattro, which is transforming immunotherapy by vaccinating against allergy with only four injections. ... A more structured process for classifying and resolving incidents.  . Pollinex Quattro allergy vaccine.

  • Yo-yoing

    R204, which marks an important step in the development of Pollinex Quattro for ragweed allergy.

  • Time for a tumble

    progress made in clinical trials, particularly that of lead product, Pollinex Quattro, a four-shot vaccination for allergy sufferers.

  • Hitting the highs and lows

    Allergy Therapeutics makes a hayfever vaccine Pollinex Quattro in Europe on a 'named patient basis'. ... Pollinex Quattro improves on this as the treatment is delivered in just four injections.

More from news
Approximately 1 fully matching, plus 6 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs


Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

InSite Events™ National Pharma Meeting: A Customer Story
How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
Fear or encouragement, which is best to drive behaviour change?
The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
The unheard, unseen, and uncorrected effects of COVID-19
The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...